 1.5 times multiplier to the applicable risk weight calculated under Rule 4.12.16(1) to any unhedged Retail Exposure to an individual where the lending currency differs from the currency of the obligor’s source of income, subject to a maximum risk weight of 150%.

(2) For the purposes of (1), a Retail Exposure is hedged if:

(a)

the obligor:

(i)

in its normal operating procedures, receives foreign currency income that matches the currency of a given Exposure, such as remittances, rental incomes or salaries; or

(ii)

has a legal contract with a Financial Institution; and

(b)

the hedge covers at least 90% of any instalment for the Exposure.

(3) An Authorised Firm may apply a 1.2 times multiplier if the following conditions

are met:

(a)

the official exchange rate between the lending currency and the currency of the obligor’s source of income is fixed via an official currency peg; and

(b) each of the currencies in (a) are issued by a central government or Central Bank that has an external credit assessment by a recognised external credit rating agency of Credit Quality Grade 1.

Subordinated debt, equity and other capital instruments

4.12.18 (1) An Authorised Firm must categorise as an equity Exposure:

(a) any instrument constituting an investment in subordinated debt, equity or

other capital instrument if:

(i)

the return of invested funds can be achieved only by the sale of the investment or sale of the rights to the investment or by the liquidation of the issuer;

(ii)

it does not place an obligation on the issuer; and

(iii)

it conveys a residual claim on the assets or income of the issuer;

(b) any instrument with the same structure as those permitted as T1 Capital

if issued by an Authorised Firm;

(c)

any instrument that places an obligation on the issuer and meets any of the following conditions:

(i)

the issuer may defer indefinitely the settlement of the obligation;

(ii)

the obligation requires (or permits at the issuer’s discretion) settlement by issue of a fixed number of the issuer’s equity shares;

119

PIB/VER50/07-25

PRUDENTIAL – INVESTMENT, INSURANCE INTERMEDIATION AND BANKING (PIB)

(iii)

the obligation requires (or permits at the issuer’s discretion) settlement by issue of a variable number of the issuer’s equity shares and (all else being equal) any change in the value of the obligation is attributable to, comparable to, and in the same direction as, the change in the value of a fixed number of the issuer’s equity shares; or

(iv)

the holder has the option to require that the obligation be settled in equity shares, unless either:

(A)

in the case of a traded instrument, the Authorised Firm has satisfied itself on reasonable grounds that the instrument trades more like the debt of the issuer than like its equity; or

(B)

in the case of non-traded instruments, the Authorised Firm has satisfied itself on reasonable grounds that the instrument should be treated as a debt position;

(d) any debt obligation and other security, partnership, derivative or other vehicle structured in a way that the economic substance is similar to the exposures referred to in points (a), (b) and (c), including liabilities from which the return is linked to that of equities; and

(e) any equity Exposure that is recorded as a loan but arises from a debt/equity swap made as part of the orderly realisation or restructuring of the debt.

(2) An Authorised Firm must not categorise as an equity Exposure:

(a) any equity investment that is structured with the intent of conveying the

economic substance of debt holdings; or

(b) any equity investment constituting a securitisation Exposure.

(3) An Authorised Firm must assign a risk weight of 250% to any equity Exposure,

unless it is:

(a) an equity investment in accordance with paragraph (4); or

(b)

required to be deducted or risk-weighted in accordance with PIB Part 3.

(4) An Authorised Firm must assign a risk weight of 400% to any equity investment in unlisted companies that are invested for short-term resale purposes or are considered venture capital or similar investments which are subject to price volatility and are acquired in anticipation of significant